Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 44 Records) |
Query Trace: BTK[original query] |
---|
Prevalence of BTK and PLCG2 mutations in a real-life CLL cohort still on ibrutinib after 3 years: a FILO group study. Blood 2019 6 134 (7): 641-644. Quinquenel Anne, Fornecker Luc-Matthieu, Letestu Rémi, Ysebaert Loïc, Fleury Carole, Lazarian Grégory, Dilhuydy Marie-Sarah, Nollet Delphine, Guieze Romain, Feugier Pierre, Roos-Weil Damien, Willems Lise, Michallet Anne-Sophie, Delmer Alain, Hormigos Katia, Levy Vincent, Cymbalista Florence, Baran-Marszak Fanny, |
Phase 2 study of the safety and efficacy of umbralisib in patients with CLL who are intolerant to BTK or PI3K? inhibitor therapy. Blood 2020 12 137 (20): 2817-2826. Mato Anthony R, Ghosh Nilanjan, Schuster Stephen J, Lamanna Nicole, Pagel John M, Flinn Ian W, Barrientos Jacqueline C, Rai Kanti R, Reeves James A, Cheson Bruce D, Barr Paul M, Kambhampati Suman, Lansigan Frederick, Pu Jeffrey J, Skarbnik Alan P, Roeker Lindsey, Fonseca Gustavo A, Sitlinger Andrea, Hamadeh Issam S, Dorsey Colleen, LaRatta Nicole, Weissbrot Hanna, Luning Prak Eline T, Tsao Patricia, Paskalis Dana, Sportelli Peter, Miskin Hari P, Weiss Michael S, Svoboda Jakub, Brander Danielle |
Primary Immunodeficiencies in India: Molecular Diagnosis and the Role of Next-Generation Sequencing. Journal of clinical immunology 2020 11 41 (2): 393-413. Arunachalam Arun Kumar, Maddali Madhavi, Aboobacker Fouzia N, Korula Anu, George Biju, Mathews Vikram, Edison Eunice Sindhu |
Predictive significance of selected gene mutations in relapsed and refractory chronic lymphocytic leukemia patients treated with ibrutinib. European journal of haematology 2020 Nov . Machnicki Marcin M, Górniak Patryk, P?pek Monika, Szymczyk Agnieszka, Iskierka-Ja?d?ewska El?bieta, Steckiewicz Pawe?, Bluszcz Aleksandra, Rydzanicz Ma?gorzata, Hus Marek, P?oski Rafa?, Makuch-?asica Hanna, Nowak Gra?yna, Juszczy?ski Przemys?aw, Jamroziak Krzysztof, Stok?osa Tomasz, Pu?a Barto |
Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib: Development and Validation of a Four-Factor Prognostic Model. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020 10 39 (6): 576-585. Ahn Inhye E, Tian Xin, Ipe David, Cheng Mei, Albitar Maher, Tsao L Claire, Zhang Lei, Ma Wanlong, Herman Sarah E M, Gaglione Erika M, Soto Susan, Dean James P, Wiestner Adri |
Circulating tumor DNA for comprehensive noninvasive monitoring of lymphoma treated with ibrutinib plus nivolumab. Blood advances 2021 9 5 (22): 4674-4685. Bruscaggin Alessio, di Bergamo Lodovico Terzi, Spina Valeria, Hodkinson Brendan, Forestieri Gabriela, Bonfiglio Ferdinando, Condoluci Adalgisa, Wu Wei, Pirosa Maria C, Faderl Martin R, Koch Ricardo, Schaffer Michael, Alvarez John D, Fourneau Nele, Gerber Bernhard, Stussi Georg, Zucca Emanuele, Balasubramanian Sriram, Rossi Davi |
Analysis of Genetic Alterations in Cutaneous Malignant Melanomas Unveils Unique Loco-Regional Variations and Novel Predictors of Metastatic Potential. The American Journal of dermatopathology 2021 4 43 (12): e185-e189. Krishnamurthy Kritika, Urioste Sophia N, Cusnir Mike, Schwartz Michael, Alghamdi Sarah, Sriganeshan Vathany, Poppiti Robe |
Activation of the MAPK pathway mediates resistance to PI3K inhibitors in chronic lymphocytic leukemia. Blood 2021 3 138 (1): 44-56. Murali Ishwarya, Kasar Siddha, Naeem Aishath, Tyekucheva Svitlana, Khalsa Jasneet K, Thrash Emily M, Itchaki Gilad, Livitz Dimitri, Leshchiner Ignaty, Dong Shuai, Fernandes Stacey M, Getz Gad, Johnson Amy, Brown Jennifer |
Autoimmune manifestations among 461 patients with monogenic inborn errors of immunity. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2021 3 32 (6): 1335-1348. Azizi Gholamreza, Tavakol Marzieh, Yazdani Reza, Delavari Samaneh, Moeini Shad Tannaz, Rasouli Seyed Erfan, Jamee Mahnaz, Pashangzadeh Salar, Kalantari Arash, Shariat Mansoureh, Shafiei Alireza, Mohammadi Javad, Hassanpour Gholamreza, Chavoshzadeh Zahra, Mahdaviani Seyed Alireza, Momen Tooba, Behniafard Nasrin, Nabavi Mohammad, Bemanian Mohammad Hassan, Arshi Saba, Molatefi Rasol, Sherkat Roya, Shirkani Afshin, Alyasin Soheila, Jabbari-Azad Farahzad, Ghaffari Javad, Mesdaghi Mehrnaz, Ahanchian Hamid, Khoshkhui Maryam, Eslamian Mohammad Hossein, Cheraghi Taher, Dabbaghzadeh Abbas, Nasiri Kalmarzi Rasoul, Esmaeilzadeh Hossein, Tafaroji Javad, Khalili Abbas, Sadeghi-Shabestari Mahnaz, Darougar Sepideh, Moghtaderi Mojgan, Ahmadiafshar Akefeh, Shakerian Behzad, Heidarzadeh Marzieh, Ghalebaghi Babak, Fathi Seyed Mohammad, Darabi Behzad, Fallahpour Morteza, Mohsenzadeh Azam, Ebrahimi Sarehsadat, Sharafian Samin, Vosughimotlagh Ahmad, Tafakoridelbari Mitra, Rahimi Haji-Abadi Maziyar, Ashournia Parisa, Razaghian Anahita, Rezaei Arezou, Salami Fereshte, Shirmast Paniz, Bazargan Nasrin, Mamishi Setareh, Khazaei Hossein Ali, Negahdari Babak, Shokri Sima, Nabavizadeh Seyed Hesamedin, Bazregari Saeed, Ghasemi Ramin, Bayat Shiva, Eshaghi Hamid, Rezaei Nima, Abolhassani Hassan, Aghamohammadi Asgh |
Response and survival predictors in a cohort of 319 patients with Waldenström macroglobulinemia treated with ibrutinib monotherapy. Blood advances 2021 12 6 (3): 1015-1024. Castillo Jorge J, Sarosiek Shayna R, Gustine Joshua N, Flynn Catherine A, Leventoff Carly R, White Timothy P, Meid Kirsten, Guerrera Maria L, Kofides Amanda, Liu Xia, Munshi Manit, Tsakmaklis Nicholas, Hunter Zachary R, Patterson Christopher J, Branagan Andrew R, Treon Steven |
[Genetic study of an X-linked agammaglobulinemia pedigree caused by an BTK mutation]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2021 11 38 (11): 1081-1086. Wei Chenxi, Yang Rujing, Yuan Xiaogeng, Yu Shihui, Qin Jianping, Tian Xinxian, Zhang M |
Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways. Blood advances 2021 10 6 (2): 637-651. Witte Hanno M, Künstner Axel, Hertel Nadine, Bernd Heinz-Wolfram, Bernard Veronica, Stölting Stephanie, Merz Hartmut, von Bubnoff Nikolas, Busch Hauke, Feller Alfred C, Gebauer Nikl |
Orelabrutinib Combined With Lenalidomide and Immunochemotherapy for Relapsed/Refractory Primary Central Nervous System Lymphoma: A Retrospective Analysis of Case Series. Frontiers in oncology 2022 7 12 901797. Yang Chuanwei, Cui Yong, Ren Xiaohui, Li Ming, Yu Kefu, Shen Shaoping, Jiang Haihui, Li Mingxiao, Zhang Xiaokang, Zhao Xuzhe, Zhu Qinghui, Lin So |
Ciliary and immune dysfunctions and their genetic background in patients with non-cystic fibrosis bronchiectasis in Central Iran. Irish journal of medical science 2022 4 192 (1): 277-283. Hassanzadeh Shakiba, Sadeghi Somayeh, Jafari Mahbube, Najafi Somayeh, Molavi Newsha, Sherkat Ro |
Utility of Bruton's Tyrosine Kinase Inhibitors in Light Chain Amyloidosis Caused by Lymphoplasmacytic Lymphoma (Waldenström's Macroglobulinemia). Advances in hematology 2022 1 2022 1182384. Bou Zerdan Maroun, Valent Jason, Diacovo Maria Julia, Theil Karl, Chaulagain Chakra |
Establishing the Molecular Diagnoses in a Cohort of 291 Patients With Predominantly Antibody Deficiency by Targeted Next-Generation Sequencing: Experience From a Monocentric Study. Frontiers in immunology 2022 1 12 786516. Rojas-Restrepo Jessica, Caballero-Oteyza Andrés, Huebscher Katrin, Haberstroh Hanna, Fliegauf Manfred, Keller Baerbel, Kobbe Robin, Warnatz Klaus, Ehl Stephan, Proietti Michele, Grimbacher Bo |
Investigation of VEGF (rs 699947) polymorphism in the progression of Rheumatoid Arthritis (RA) and in-silico nanoparticle drug delivery of potential phytochemicals to cure RA. Acta biochimica Polonica 2023 9 . Nageen Hussain, Mohsin Mumtaz, Mohammad Adil, Abad Ali Nadeem, Abid Sarwar, Tariq Aziz, Metab Alharbi, Abdulrahman Alshammari, Abdullah F Alasmari, Mousa Essa Alhar |
Genetic Predictors of Ibrutinib-Related Cardiovascular Side Effects in Patients with Chronic Lymphocytic Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 9 . Issam S Hamadeh, Jai N Patel, Ryan Jacobs, Hang Zeng, Jiaxian He, Bei Hu, Tamara Kay Moyo, Amy Soni, Steven Park, Ed Copelan, Belinda Avalos, Alicia Hamilton, Nury Steuerwald, Nilanjan Gho |
Genetic diagnosis of inborn errors of immunity using clinical exome sequencing. Frontiers in immunology 2023 6 14 1178582. Soon Sung Kwon, Youn Keong Cho, Seungmin Hahn, Jiyoung Oh, Dongju Won, Saeam Shin, Ji-Man Kang, Jong Gyun Ahn, Seung-Tae Lee, Jong Rak Ch |
B-cell receptor pathway mutations are infrequent in patients with chronic lymphocytic leukemia on continuous ibrutinib therapy. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 6 . Jennifer A Woyach, Paolo Ghia, John C Byrd, Inhye E Ahn, Carol Moreno, Susan M O'Brien, Daniel Jones, Leo W K Cheung, Elizabeth Chong, Kevin Kwei, James P Dean, Danelle F James, Adrian Wiestn |
CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 5 OF1-OF10. Anfal Alsadhan, Jonathan Chen, Erika M Gaglione, Chingiz Underbayev, Pamela L Tuma, Xin Tian, Lita A Freeman, Sivasubramanian Baskar, Pia Nierman, Susan Soto, Andy Itsara, Inhye E Ahn, Clare Sun, Elena Bibikova, Tanja Nicole Hartmann, Maissa Mhibik, Adrian Wiestn |
Clinical Features and Genetic Analysis of Taiwanese Primary Immunodeficiency Patients with Prolonged Diarrhea and Monogenetic Inflammatory Bowel Disease. Journal of clinical immunology 2023 5 . Wen-I Lee, Chien-Chang Chen, Shih-Hsiang Chen, Wan-Tz Lai, Tang-Her Jaing, Liang-Shiou Ou, Chi-Jou Liang, Chen-Chen Kang, Jing-Long Hua |
Bruton's tyrosine kinase (BTK) gene overexpression is associated with risk of lymphoma in primary Sjögren's syndrome. Arthritis & rheumatology (Hoboken, N.J.) 2023 4 . Pierre-Marie Duret, Cedric Schleiss, Lou Kawka, Nicolas Meyer, Tao Ye, Alain Saraux, Valérie Devauchelle-Pensec, Raphaele Seror, Claire Larroche, Aleth Perdriger, Jean Sibilia, Laurent Vallat, Luc-Matthieu Fornecker, Gaetane Nocturne, Xavier Mariette, Jacques-Eric Gottenbe |
The outcome of ibrutinib-based regimens in relapsed/refractory central nervous system lymphoma and the potential impact of genomic variants. Advances in clinical and experimental medicine : official organ Wroclaw Medical University 2023 3 . Wang Shu, Zhu Yuqi, Qian Xiaohan, Ding Tianling, Yuan Yan, Li Yuan, Wu Hanfeng, Chen To |
Molecular associations of response to the new generation BTK inhibitor zanubrutinib in marginal zone lymphoma. Blood advances 2023 3 . Tatarczuch Maciej, Waltham Mark, Shortt Jake, Polekhina Galina, Hawkes Eliza A, Ho Shir-Jing, Trotman Judith, Brasacchio Daniella, Co Melannie, Li Jessica, Ramakrishnan Vanitha, Dunne Karin, Opat Stephen S, Gregory Gareth |
The Autoimmune Manifestations in Patients with Genetic Defects in the B Cell Development and Differentiation Stages. Journal of clinical immunology 2023 2 . Azizi Gholamreza, Hesari Mina Fattah, Sharifinejad Niusha, Fayyaz Farimah, Chavoshzadeh Zahra, Mahdaviani Seyed Alireza, Alan Mahnaz Seifi, Jamee Mahnaz, Tavakol Marzieh, Sadri Homa, Shahrestanaki Ehsan, Nabavi Mohammad, Ebrahimi Sareh Sadat, Shirkani Afshin, Vosughi Motlagh Ahmad, Delavari Samaneh, Rasouli Seyed Erfan, Esmaeili Marzie, Salami Fereshte, Yazdani Reza, Rezaei Nima, Abolhassani Hass |
Ibrutinib and venetoclax as primary therapy in symptomatic treatment naïve Waldenström macroglobulinemia. Blood 2023 11 . Jorge J Castillo, Andrew R Branagan, David Sermer, Catherine Flynn, Kirsten E Meid, Megan Little, Katherine Stockman, Timothy P White, Alexa G Canning, Maria Luisa Guerrera, Amanda Kofides, Shirong Liu, Xia Liu, Kris Richardson, Nicholas Tsakmaklis, Christopher J Patterson, Zachary R Hunter, Steven P Treon, Shayna Sarosi |
Absence of BTK, BCL2, and PLCG2 Mutations in Chronic Lymphocytic Leukemia Relapsing after First-Line Treatment with Fixed-Duration Ibrutinib plus Venetoclax. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 11 OF1-OF8. Nitin Jain, Lisa J Croner, John N Allan, Tanya Siddiqi, Alessandra Tedeschi, Xavier C Badoux, Karl Eckert, Leo W K Cheung, Anwesha Mukherjee, James P Dean, Edith Szafer-Glusman, John F Seymo |
BTK and PLCG2 remain unmutated in one third of patients with CLL relapsing on ibrutinib. Blood advances 2023 1 . Bonfiglio Silvia, Sutton Lesley-Ann, Ljungström Viktor, Capasso Antonella, Pandzic Tatjana, Weström Simone, Foroughi-Asl Hassan, Skaftason Aron, Gellerbring Anna, Lyander Anna, Gandini Francesca, Gaidano Gianluca, Trentin Livio, Bonello Lisa, Reda Gianluigi, Bödör Csaba, Stavroyianni Niki, Tam Constantine S, Marasca Roberto, Forconi Francesco, Panayiotidis Panayiotis, Ringshausen Ingo, Jaksic Ozren, Frustaci Anna Maria, Iyengar Sunil, Coscia Marta, Mulligan Stephen P, Ysebaert Loïc, Strugov Vladimir, Pavlovsky Carolina, Walewska Renata, Österborg Anders, Cortese Diego, Ranghetti Pamela, Baliakas Panagiotis, Stamatopoulos Kostas, Scarfò Lydia, Rosenquist Richard, Ghia Pao |
Role of Skewed X-Chromosome Inactivation in Common Variable Immunodeficiency. Journal of clinical immunology 2024 1 44 (2): 54. Marina Garcia-Prat, Laura Batlle-Masó, Alba Parra-Martínez, Clara Franco-Jarava, Mónica Martinez-Gallo, Aina Aguiló-Cucurull, Janire Perurena-Prieto, Neus Castells, Blanca Urban, Romina Dieli-Crimi, Pere Soler-Palacín, Roger Colobr |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: